510(k) Report

510(k) · Cleared

Cleared

Bta Stat Test Prescription Home Use

K974845510(k) TraditionalCleared Dec 8, 1998355-day reviewClass II21 CFR 866.6010

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bard Diagnostic Sciences,Inc. · MMW System, Test, Tumor Marker, Monitoring, Bladder

Cleared on Dec 8, 1998 as substantially equivalent to K964151 (Bard Diagnostic Sciences,Inc., 1997) after a 355-day review. Its family tree reaches back 1 generation to 1997.

Decided
Dec 8, 1998
Review
355 days
Class
Class II
Product code
MMW
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K964151 (1997). No later device cites it as a predicate yet.

K964151 · Bard and Bta Test · Bard Diagnostic Sciences,Inc. · 1997199619982000
K964151 · Bard and Bta Test · Bard Diagnostic Sciences,Inc. · 19970
  1. Root · 1 generation backK964151 Bard and Bta TestBard Diagnostic Sciences,Inc. · 1997
  2. This deviceK974845 Bta Stat Test Prescription Home UseBard Diagnostic Sciences,Inc. · 1998
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K964151Bard and Bta TestBard Diagnostic Sciences,Inc.1997—
0 (this device)K974845Bta Stat Test Prescription Home UseBard Diagnostic Sciences,Inc.1998—
FIG. 1 — Lineage of K974845, 1997–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MMW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MMW device

  1. #1 K203245 Bladder EpiCheck DNA extraction kit…score 5.3 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K964151Bard and Bta Test
Summary page 1
…TA stat Test Common/Usual Name: BTA stat Test Classification Name: Tumor Associated Antigen Immunological Test System C. Predicate Device Name: Trade Name: BTA stat Test K964151 Bion Diagnostic Sciences claims substantial equivalence to the above mentioned test. The new 510(k) 1s for the addition of an in…
Bard Diagnostic Sciences,Inc.1997—

Also cleared against K964151: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 2 other devices also cite its predicate K964151.

How does its category compare?

All MMW devices

MMW System, Test, Tumor Marker, Monitoring, Bladder: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MMW

1in 2023

2023: 1
2007high 1 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MMW

Too few MMW 510(k)s in any year since 2007 to give a median.

Recalls per year · MMW

No recall names MMW since 2007.

Adverse event reports per year · MMW

1in 2013

2010: 12011: 12012: 32013: 1
2007high 3 (2012) · low 0 (2007)2025

MAUDE reports naming product code MMW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—01
20110—01
20120—03
20130—01
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20231—00
20240—00
20250—00
20260—0—

What is it indicated for?

The BTA stat test is indicated for use as an aid in the management of bladder cancer patients in conjunction with cystoscopy. This 510(k) is to expand the same indication to prescription home use of the product. The original 510(k) was K964151.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K974845: Bta Stat Test Prescription Home Use.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K974845

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026